Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    2-day In-person Seminar on Why is FDA at my Facility, and What do I do During an Inspection at Singapore

    View: 108

    Website http://bit.ly/1cnyZfV | Want to Edit it Edit Freely

    Category Seminar, Health, Medical, Pharma, Clinical

    Deadline: February 06, 2014 | Date: February 07, 2014-February 08, 2014

    Venue/Country: Singapore, Singapore

    Updated: 2014-01-07 13:43:55 (GMT+9)

    Call For Papers - CFP

    Overview:

    Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer. This presentation will review and emphasize the do's and don'ts and cardinal rules as to interviewing, how to respond, reviewing documentation, etiquette, use of certain words, body language, responding to questions/requests, etc., and certainly replying to 483's and Warning Letters. Emphasis is placed on the company's SOP on dealing with inspectors and knowing how to be prepared, proactive...and being able to defend and justify... and what it takes to achieve a favorable outcome. This seminar provides background and understanding of the role played by the Agency, its administrative and enforcement powers. It takes the participant step by step through the entire inspection process and describes various types of inspections.

    Course Description:

    Day 1 ? Agenda

    Lecture 1: How a firm should prepare for an FDA inspection

    Lecture 2: Ways to train employees in view of the inspection

    Lecture 3: How to ensure that required documentation is in place

    Lecture 4: How to interact with the investigator-DO's and DON'T's

    Lecture 5: What companies should do when the inspection ends

    Lecture 6: How to reply to 483's and warning letters

    Lecture 7: Legal implications of non-compliance

    Lecture 8: Post inspection actions

    Day 2 ? Agenda

    Lecture 1: Why inspections are conducted and by what statutory authority

    Lecture 2: The emphasis on systems-based inspections...and the IOM and other crucial FDA reference documents

    Lecture 3: What is subject to FDA purview and what's off-limits

    Lecture 4: Understand and apply the do's and don'ts and comprehend that preparation is the key to success

    Lecture 5: What are the prohibited "Acts" and the enforcement categories that you need to deal with

    Lecture 6: What you need to know and do to prepare for, during and even after the inspection...and why your inspection response team is key

    Lecture 7: The company's Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnel

    Lecture 8: How to respond to findings and facilitating the documentation and remediation process...and reaching final closure

    Lecture 9: Define clear responsibilities, roles and goals for personnel involved in SOP development

    Who Will Benefit:

    Industries: Departments Types of facilities:

    1. FDA regulated Industries

    Medical Device

    Pharmaceuticals

    Clinical

    2. Dietary Supplements

    Food

    Nutraceutical

    3. Healthcare IT

    Technical Services

    Validation

    Engineering

    Top and Middle Management

    Quality Assurance/Management

    Compliance Management

    Manufacturing

    Laboratory

    Regulatory Affairs

    Information Technology

    Marketing & Sales

    Operations

    Research & Development

    Manufacturing facilities

    Contract manufacturing facilities

    Distributors

    Packaging, Labeling

    API Suppliers

    Laboratories

    Importers

    Documentation Management

    About Speaker:

    David R. Dills

    Regulatory Affairs & Compliance Consultant,

    David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements.

    DATE, VENUE & PRICE:

    Location: Singapore| 6th & 7th February 2014 | 9 AM to 6 PM

    Venue: WILL BE ANNOUNCED SOON

    Price: $1,595.00

    Register now and save $200. (Early Bird)

    Until January10, Early Bird Price: $1,595.00

    From January11 to February04, Regular Price: $1,795.00

    Contact Information:

    Event Coordinator

    Call: +65-3158-3448

    Toll free: 1800 447 9407

    Fax: 302 288 6884

    Email: supportatglobalcompliancepanel.com

    Website: https://www.globalcompliancepanel.com

    LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.php

    EVENT Link - http://bit.ly/1cnyZfV

    NetZealous LLC,

    DBA GlobalCompliancePanel,

    161 Mission Falls Lane,

    Suite 216, Fremont, CA 94539, USA

    Phone: 1800 447 9407


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.